Work

Abstract A249: Navitoclax and veliparib yield cytotoxicity with lower doses than used for single agents in women's cancers.

Year: 2013

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-13-a249

Authors: Jung-Min Lee, Alyssa Stacy, Minshu Yu, Elise C. Kohn

Institution: National Cancer Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1998670116

Cites:

Cited by: 2

Related to: 10